KRAS-activated PRKCD promotes growth, invasion, and migration of cancer cells, through MAPK signalling in NSCLC cell lines (and mouse model), whereas PRKCD activation in cells without active KRAS leads to tumour suppression92. The gene discussed is KRAS; the disease is neoplasm.